Zobrazeno 1 - 10 of 33 pro vyhledávání: '"LM Riou"'
1
Abstracts of Original Contributions Cardiovascular Molecular Imaging Symposium May 3–4, 2004 Bethesda, Maryland
Autor: T Lahoutte, C Vanhove, V Caveliers, M Defrise, H Everaert, A Bossuyt, P. R. Franken, K. P. Schäfers, M. Kriens, C. Barnard, O. Schober, M. Schäfers, K Kopka, S Wagner, MP Law, B Riemann, VW Pike, P Herrero, CS Dence, Z Kisrieva-Ware, P Eisenbeis, MJ Welch, RJ Gropler, J Bucerius, AY Joe, J Schmaliohann, D Gündisch, MJ Reinhardt, H-J Biersack, U Wüllner, DF Ranney, RM Peshock, GG McDonald, PJ Slomka, RA deKemp, RSB Beanlands, H Nishina, A Abidov, DS Berman, G Germano, LM Riou, AR Goode, K Hatada, M Ruiz, R Lima, TD Harris, GA Beller, DK Glover, H Kim, MH Miceli, D Delbeke, P Bhargava, LB Jones Jackson, RC Walker, E Anaissie, A Alavi, SM Hanrahan, M Janabi, SE Taylor, JJ Rychak, AL Klibanov, A Leppanen, RD Cummings, K Ley, J Hossack, AI Veress, B Feng, Y Yang, JA Weiss, RH Huesman, GT Gullberg, TL Sharp, JA Englebach, NM Fettig, LW Dobrucki, J Hua, BN Bourke, MM Sadeghi, P Cavaliere, M Mendizabal, N VanRoyen, IR Buschmann, AJ Sinusas, J Zhang, HR Fassaei, S Krassilnikova, L Esmailzadeh, AA Gharaei, A Kooshkabadi, DS Edwards, P Yalamanchili, BL Zaret, JR Bender, FH Epstein, WD Gilson, FC Sureau, Z Yang, BA French, S Lewis, XE Lu, EM Tom, MM Felix, JE Gretton, RP Varghese, WR Wagner, FS Villanueva
Publikováno v: Journal of Nuclear Cardiology. 11:367-373
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fcba881f0e2158dafc8628e7b1cea300
https://doi.org/10.1007/bf02972758
Zobrazit plný text záznamu
3
Akademický článek
Regional CZT myocardial perfusion reserve for the detection of territories with simultaneously impaired CFR and IMR in patients without obstructive coronary artery disease: a pilot study.
Autor: Djaïleb L; Nuclear Medicine Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France. LDjaileb@chu-grenoble.fr., De Leiris N; Nuclear Medicine Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France., Canu M; Cardiology Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France., Sy OP; Nuclear Medicine Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France., Seiller A; Clinical Investigation Center-Technological Innovation, INSERM CIC1406, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France., Leenhardt J; Nuclear Medicine Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France., Charlon C; Cardiology Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France., Faure M; Nuclear Medicine Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France., Caillard J; Nuclear Medicine Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France., Broisat A; INSERM, LRB, Univ. Grenoble Alpes, 38000, Grenoble, France., Borel AL; Endocrinology Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France., Lablanche S; Endocrinology Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France., Betry C; Endocrinology Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France., Ghezzi C; INSERM, LRB, Univ. Grenoble Alpes, 38000, Grenoble, France., Vanzetto G; Cardiology Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France., Fagret D; Nuclear Medicine Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France., Riou LM; INSERM, LRB, Univ. Grenoble Alpes, 38000, Grenoble, France., Barone-Rochette G; Cardiology Department, LRB, INSERM, CHU Grenoble Alpes, Univ. Grenoble Alpes, 38000, Grenoble, France.
Publikováno v: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology [J Nucl Cardiol] 2023 Aug; Vol. 30 (4), pp. 1656-1667. Date of Electronic Publication: 2023 Feb 22.
Zobrazit plný text záznamu
4
Akademický článek
Noninvasive assessment of coronary microvascular dysfunction using SPECT myocardial perfusion imaging and myocardial perfusion entropy quantification in a rodent model of type 2 diabetes.
Autor: Carabelli A; Univ. Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, 38000, Grenoble, France.; UMR UGA-INSERM U1039 Radiopharmaceutiques Biocliniques, Faculté de Médecine La Tronche, Isere, France., Canu M; Univ. Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, 38000, Grenoble, France., de Fondaumière M; Univ. Grenoble Alpes, INSERM, LRB, 38000, Grenoble, France., Debiossat M; Univ. Grenoble Alpes, INSERM, LRB, 38000, Grenoble, France., Leenhardt J; Univ. Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, 38000, Grenoble, France., Broisat A; Univ. Grenoble Alpes, INSERM, LRB, 38000, Grenoble, France., Ghezzi C; Univ. Grenoble Alpes, INSERM, LRB, 38000, Grenoble, France., Vanzetto G; Univ. Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, 38000, Grenoble, France., Fagret D; Univ. Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, 38000, Grenoble, France., Barone-Rochette G; Univ. Grenoble Alpes, INSERM, CHU Grenoble Alpes, LRB, 38000, Grenoble, France., Riou LM; UMR UGA-INSERM U1039 Radiopharmaceutiques Biocliniques, Faculté de Médecine La Tronche, Isere, France. Laurent.Riou@univ-grenoble-alpes.fr.; Univ. Grenoble Alpes, INSERM, LRB, 38000, Grenoble, France. Laurent.Riou@univ-grenoble-alpes.fr.
Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Feb; Vol. 49 (3), pp. 809-820. Date of Electronic Publication: 2021 Aug 21.
Zobrazit plný text záznamu
5
Akademický článek
Prognostic value of SPECT myocardial perfusion entropy in high-risk type 2 diabetic patients.
Autor: Djaileb L; Nuclear Medicine Department, Grenoble-Alpes University Hospital, Grenoble, France. LDjaileb@chu-grenoble.fr.; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France. LDjaileb@chu-grenoble.fr., Seiller A; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France., Canu M; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France.; Cardiology Department, Grenoble-Alpes University Hospital, Grenoble, France., De Leiris N; Nuclear Medicine Department, Grenoble-Alpes University Hospital, Grenoble, France.; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France., Martin A; Cardiology Department, Clinique Mutualiste, Grenoble, France., Poujol J; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France., Fraguas-Rubio A; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France., Leenhardt J; Nuclear Medicine Department, Grenoble-Alpes University Hospital, Grenoble, France.; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France., Carabelli A; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France.; Cardiology Department, Grenoble-Alpes University Hospital, Grenoble, France., Calizzano A; Nuclear Medicine Department, Grenoble-Alpes University Hospital, Grenoble, France.; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France., De Fondaumière M; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France., Broisat A; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France., Desvignes M; GIPSA-lab, CNRS, UMR 5216, Grenoble, France., Vanzetto G; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France.; Cardiology Department, Grenoble-Alpes University Hospital, Grenoble, France., Ghezzi C; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France., Fagret D; Nuclear Medicine Department, Grenoble-Alpes University Hospital, Grenoble, France.; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France., Riou LM; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France., Barone-Rochette G; Radiopharmaceutiques Biocliniques, UMR UGA-INSERM U1039, Grenoble, France.; Cardiology Department, Grenoble-Alpes University Hospital, Grenoble, France.
Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Jun; Vol. 48 (6), pp. 1813-1821. Date of Electronic Publication: 2020 Nov 20.
Zobrazit plný text záznamu
6
Akademický článek
Prospective diagnostic performance of semiconductor SPECT myocardial perfusion imaging: wall thickening analysis reduces the need for an additional prone acquisition.
Autor: Djaileb L; INSERM, U1039, Radiopharmaceutiques Biocliniques, Faculté de Médecine de Grenoble, F-38700, La Tronche, France.; Université Grenoble-Alpes, Grenoble-Alpes, France.; Nuclear Medicine Department, Grenoble-Alpes University Hospital, Grenoble-Alpes, France., Dubois B; Nuclear Medicine Department, Savoie Metropole Hospital, Chambery, France., de Leiris N; INSERM, U1039, Radiopharmaceutiques Biocliniques, Faculté de Médecine de Grenoble, F-38700, La Tronche, France.; Nuclear Medicine Department, Grenoble-Alpes University Hospital, Grenoble-Alpes, France., Leenhardt J; INSERM, U1039, Radiopharmaceutiques Biocliniques, Faculté de Médecine de Grenoble, F-38700, La Tronche, France.; Nuclear Medicine Department, Grenoble-Alpes University Hospital, Grenoble-Alpes, France., Canu M; INSERM, U1039, Radiopharmaceutiques Biocliniques, Faculté de Médecine de Grenoble, F-38700, La Tronche, France., Sy OP; Nuclear Medicine Department, Grenoble-Alpes University Hospital, Grenoble-Alpes, France., Carabelli A; INSERM, U1039, Radiopharmaceutiques Biocliniques, Faculté de Médecine de Grenoble, F-38700, La Tronche, France.; Cardiology Department, Grenoble-Alpes University Hospital, Grenoble-Alpes, France., Boussat B; TIMC-IMAG, UMR CNRS 5525, Grenoble-Alpes, France., Dumas L; INSERM, U1039, Radiopharmaceutiques Biocliniques, Faculté de Médecine de Grenoble, F-38700, La Tronche, France.; Université Grenoble-Alpes, Grenoble-Alpes, France., Broisat A; INSERM, U1039, Radiopharmaceutiques Biocliniques, Faculté de Médecine de Grenoble, F-38700, La Tronche, France.; Université Grenoble-Alpes, Grenoble-Alpes, France., Vanzetto G; INSERM, U1039, Radiopharmaceutiques Biocliniques, Faculté de Médecine de Grenoble, F-38700, La Tronche, France.; Université Grenoble-Alpes, Grenoble-Alpes, France.; Cardiology Department, Grenoble-Alpes University Hospital, Grenoble-Alpes, France., Fagret D; INSERM, U1039, Radiopharmaceutiques Biocliniques, Faculté de Médecine de Grenoble, F-38700, La Tronche, France.; Université Grenoble-Alpes, Grenoble-Alpes, France.; Nuclear Medicine Department, Grenoble-Alpes University Hospital, Grenoble-Alpes, France., Ghezzi C; INSERM, U1039, Radiopharmaceutiques Biocliniques, Faculté de Médecine de Grenoble, F-38700, La Tronche, France.; Université Grenoble-Alpes, Grenoble-Alpes, France., Barone-Rochette G; INSERM, U1039, Radiopharmaceutiques Biocliniques, Faculté de Médecine de Grenoble, F-38700, La Tronche, France.; Université Grenoble-Alpes, Grenoble-Alpes, France.; Cardiology Department, Grenoble-Alpes University Hospital, Grenoble-Alpes, France., Riou LM; INSERM, U1039, Radiopharmaceutiques Biocliniques, Faculté de Médecine de Grenoble, F-38700, La Tronche, France. Laurent.Riou@univ-grenoble-alpes.fr.; Université Grenoble-Alpes, Grenoble-Alpes, France. Laurent.Riou@univ-grenoble-alpes.fr.
Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2019 Sep; Vol. 46 (10), pp. 2042-2050. Date of Electronic Publication: 2019 Jul 18.
Zobrazit plný text záznamu
7
Akademický článek
Sympathetic cardiac function in early sepsis: Noninvasive evaluation with [ 123 I]-meta-iodobenzylguanidine ( 123 I-MIBG) in vivo SPECT imaging.
Autor: Clerc R; INSERM U1039, Radiopharmaceutiques Biocliniques, Grenoble, France.; Université Grenoble Alpes, Grenoble, France., Doll S; INSERM U1039, Radiopharmaceutiques Biocliniques, Grenoble, France.; Université Grenoble Alpes, Grenoble, France., Riou LM; INSERM U1039, Radiopharmaceutiques Biocliniques, Grenoble, France. Laurent.Riou@univ-grenoble-alpes.fr.; Université Grenoble Alpes, Grenoble, France. Laurent.Riou@univ-grenoble-alpes.fr.; INSERM U1039, Faculté de Médecine de Grenoble, 38700, La Tronche, France. Laurent.Riou@univ-grenoble-alpes.fr., Perret P; INSERM U1039, Radiopharmaceutiques Biocliniques, Grenoble, France.; Université Grenoble Alpes, Grenoble, France., Broisat A; INSERM U1039, Radiopharmaceutiques Biocliniques, Grenoble, France.; Université Grenoble Alpes, Grenoble, France., Soubies A; INSERM U1039, Radiopharmaceutiques Biocliniques, Grenoble, France.; Université Grenoble Alpes, Grenoble, France., Desruet MD; INSERM U1039, Radiopharmaceutiques Biocliniques, Grenoble, France.; Nuclear Medicine Department, Grenoble University Hospital, Grenoble, France., Fagret D; INSERM U1039, Radiopharmaceutiques Biocliniques, Grenoble, France.; Nuclear Medicine Department, Grenoble University Hospital, Grenoble, France., Schwebel C; INSERM U1039, Radiopharmaceutiques Biocliniques, Grenoble, France.; Université Grenoble Alpes, Grenoble, France.; Intensive Care Unit, Grenoble University Hospital, Grenoble, France., Ghezzi C; INSERM U1039, Radiopharmaceutiques Biocliniques, Grenoble, France.; Université Grenoble Alpes, Grenoble, France.
Publikováno v: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology [J Nucl Cardiol] 2018 Apr; Vol. 25 (2), pp. 483-491. Date of Electronic Publication: 2016 Aug 29.
Zobrazit plný text záznamu
8
Akademický článek
Biodistribution and preliminary toxicity studies of nanoparticles made of Biotransesterified β-cyclodextrins and PEGylated phospholipids.
Autor: Perret P; INSERM, UMR 1039, Radiopharmaceutiques Biocliniques, Grenoble-Alpes University, France., Bacot S; INSERM, UMR 1039, Radiopharmaceutiques Biocliniques, Grenoble-Alpes University, France., Gèze A; DPM, UMR CNRS 5063, ICMG FR 2607, Faculty of Pharmacy, Grenoble-Alpes University, France., Gentil Dit Maurin A; DPM, UMR CNRS 5063, ICMG FR 2607, Faculty of Pharmacy, Grenoble-Alpes University, France., Debiossat M; INSERM, UMR 1039, Radiopharmaceutiques Biocliniques, Grenoble-Alpes University, France., Soubies A; INSERM, UMR 1039, Radiopharmaceutiques Biocliniques, Grenoble-Alpes University, France., Blanc-Marquis V; DPM, UMR CNRS 5063, ICMG FR 2607, Faculty of Pharmacy, Grenoble-Alpes University, France., Choisnard L; DPM, UMR CNRS 5063, ICMG FR 2607, Faculty of Pharmacy, Grenoble-Alpes University, France., Boutonnat J; CHU Grenoble-Alpes - TIMC UMR CNRS 5525, France., Ghezzi C; INSERM, UMR 1039, Radiopharmaceutiques Biocliniques, Grenoble-Alpes University, France., Putaux JL; CERMAV-CNRS, UPR 5301, ICMG FR 2607, Grenoble-Alpes University, France., Lancelon-Pin C; CERMAV-CNRS, UPR 5301, ICMG FR 2607, Grenoble-Alpes University, France., Riou LM; INSERM, UMR 1039, Radiopharmaceutiques Biocliniques, Grenoble-Alpes University, France. Electronic address: Laurent.Riou@univ-grenoble-alpes.fr., Wouessidjewe D; DPM, UMR CNRS 5063, ICMG FR 2607, Faculty of Pharmacy, Grenoble-Alpes University, France.
Publikováno v: Materials science & engineering. C, Materials for biological applications [Mater Sci Eng C Mater Biol Appl] 2018 Apr 01; Vol. 85, pp. 7-17. Date of Electronic Publication: 2017 Dec 15.
Zobrazit plný text záznamu
9
Akademický článek
Evaluation of Antiatherogenic Properties of Ezetimibe Using 3 H-Labeled Low-Density-Lipoprotein Cholesterol and 99m Tc-cAbVCAM1-5 SPECT in ApoE -/- Mice Fed the Paigen Diet.
Autor: Dumas LS; INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France.; UGA, Université Grenoble Alpes, Grenoble, France.; Advanced Accelerator Applications, Saint-Genis-Pouilly, France., Briand F; Physiogenex, Labège, France., Clerc R; INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France.; UGA, Université Grenoble Alpes, Grenoble, France.; Physiogenex, Labège, France., Brousseau E; Physiogenex, Labège, France., Montemagno C; INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France.; UGA, Université Grenoble Alpes, Grenoble, France., Ahmadi M; INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France.; UGA, Université Grenoble Alpes, Grenoble, France., Bacot S; INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France.; UGA, Université Grenoble Alpes, Grenoble, France., Soubies A; INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France.; UGA, Université Grenoble Alpes, Grenoble, France., Perret P; INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France.; UGA, Université Grenoble Alpes, Grenoble, France., Riou LM; INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France.; UGA, Université Grenoble Alpes, Grenoble, France., Devoogdt N; ICMI, Vrije Universiteit Brussel, Brussels, Belgium; and., Lahoutte T; ICMI, Vrije Universiteit Brussel, Brussels, Belgium; and., Barone-Rochette G; INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France.; UGA, Université Grenoble Alpes, Grenoble, France.; CHRU Grenoble, Hôpital Michallon, Grenoble, France., Fagret D; INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France.; UGA, Université Grenoble Alpes, Grenoble, France.; CHRU Grenoble, Hôpital Michallon, Grenoble, France., Ghezzi C; INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France.; UGA, Université Grenoble Alpes, Grenoble, France., Sulpice T; Physiogenex, Labège, France., Broisat A; INSERM U1039 Radiopharmaceutiques Biocliniques, Grenoble, France alexis.broisat@inserm.fr.; UGA, Université Grenoble Alpes, Grenoble, France.
Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2017 Jul; Vol. 58 (7), pp. 1088-1093. Date of Electronic Publication: 2017 Mar 09.
Zobrazit plný text záznamu
10
Akademický článek
Targeted radionuclide therapy with RAFT-RGD radiolabelled with (90)Y or (177)Lu in a mouse model of αvβ3-expressing tumours.
Autor: Bozon-Petitprin A; INSERM, U1039, Grenoble, 38000, France., Bacot S, Gauchez AS, Ahmadi M, Bourre JC, Marti-Batlle D, Perret P, Broisat A, Riou LM, Claron M, Boturyn D, Fagret D, Ghezzi C, Vuillez JP
Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2015 Feb; Vol. 42 (2), pp. 252-63. Date of Electronic Publication: 2014 Aug 28.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje